Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             11 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A phase I–II study of rituximab, ifosfamide, mitoxantrone andetoposide (R-IME) for B cell non-Hodgkin’s lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT) Joyce, R.M.

14 S1 p. i21-i27
artikel
2 Current role and future perspectives for ifosfamide in the treatment of malignant non-Hodgkin’s lymphoma—resultsfrom an expert meeting Sneller, V.

14 S1 p. i1-i3
artikel
3 Hodgkin’s lymphoma: what is next in salvage treatment? Gisselbrecht, C.

14 S1 p. i37-i38
artikel
4 Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin’s lymphoma Zelenetz, A.D.

14 S1 p. i5-i10
artikel
5 Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin’s lymphoma and Hodgkin’s disease: the Italian experience Zinzani, P.L.

14 S1 p. i43-i45
artikel
6 Ifosfamide salvage treatment before autologous stem cell transplantation in patients with refractory and relapsed Hodgkin’s lymphoma: a GELA experience Gisselbrecht, C.

14 S1 p. i39-i41
artikel
7 Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients Nowrousian, M.R.

14 S1 p. i29-i36
artikel
8 Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin’s lymphoma and Hodgkin’s disease Hertzberg, M.S.

14 S1 p. i11-i16
artikel
9 Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin’s lymphoma Vose, J.

14 S1 p. i17-i20
artikel
10 Strategic approach to the management of Hodgkin’s disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK) Proctor, S.J.

14 S1 p. i47-i50
artikel
11 Table of Contents
14 S1 p. ii
artikel
                             11 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland